Potentiation of cytotoxicity of paclitaxel in combination with Cl-IB-MECA in human C32 metastatic melanoma cells: A new possible therapeutic strategy for melanoma-Reference-Cited by-同舟云学术

Potentiation of cytotoxicity of paclitaxel in combination with Cl-IB-MECA in human C32 metastatic melanoma cells: A new possible therapeutic strategy for melanoma

Published:2013-10 Issue:8 Volume:67 Page:777-789
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Soares Ana S.,Costa Vera M.,Diniz Carmen,Fresco Paula

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference77 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. From melanocyte to metastatic malignant melanoma;Bandarchi;Dermatol Res Pract,2010

3. Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma;Chen;Pigment Cell Melanoma Res,2009

4. DNA repair pathways in drug resistance in melanoma;Bradbury;Anticancer Drugs,2004

5. Upregulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress;Jiang;Cancer Res,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of the potential toxicity of adrenaline to neurons, using the SH-SY5Y human cellular model;Brazilian Journal of Pharmaceutical Sciences;2023

2. 2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines;International Journal of Molecular Medicine;2022-01-18

3. Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations;Archives of Toxicology;2020-09-07

4. Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells;Biomolecules;2019-01-10

5. Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A ‘Chemobrain’ In Vitro Study;Pharmaceuticals;2018-05-05